2019 annual financial data

Candel Therapeutics 2019 Operating margin

Direct answer

Operating margin was -7,229.6%.

Operating income was -9.04M USD and net income was -8.24M USD.
Operating cash flow was Not available.

Get free Candel Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
125,000 USD
Operating income
-9.04M USD
Net income
-8.24M USD
Operating cash flow
Not available